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TTXThe kinesin superfamily ofmotorproteins is known to beATP-dependent transporters of various types of cargoes.
In neurons, KIF17 is found to transport vesicles containing theN-methyl-D-aspartate receptor NR2B subunit from
the cell body speciﬁcally to the dendrites. These subunits are intimately associated with glutamatergic
neurotransmission as well as with learning and memory. Glutamatergic synapses are highly energy-dependent,
and recently we found that the same transcription factor, nuclear respiratory factor 1 (NRF-1), co-regulates
energy metabolism (via its regulation of cytochrome c oxidase and other mitochondrial enzymes) and
neurochemicals of glutamatergic transmission (NR1, NR2B, GluR2, and nNOS). The present study tested our
hypothesis that NRF-1 also transcriptionally regulates KIF17. By means of in silico analysis, electrophoretic
mobility shift and supershift assays, in vivo chromatin immunoprecipitation assays, promoter mutations, and
real-time quantitative PCR,we found that NRF-1 (but not NRF-2) functionally regulates Kif17, but not Kif1a, gene.
NRF-1 binding sites on Kif17 gene are highly conserved among mice, rats, and humans. Silencing of NRF-1 with
small interference RNA blocked the up-regulation of Kif17mRNA and proteins (and ofGrin1 and Grin2b) induced
by KCl-mediated depolarization, whereas over-expressing NRF-1 rescued these transcripts and proteins from
being suppressed by TTX. Thus, NRF-1 co-regulates oxidative enzymes that generate energy and neurochemicals
that consume energy related to glutamatergic neurotransmission, such as KIF17, NR1, and NR2B, thereby
ensuring that energy production matches energy utilization at the molecular and cellular levels.; CMV, cytomegalovirus; COX,
y shift assay; LTP, long-term
1, nuclear respiratory factor 1;
n RNA; Sp1, speciﬁcity protein
transcription start point; TTX,
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The kinesin superfamily proteins (KIFs) transport membranous
organelles, protein complexes, and mRNAs to speciﬁc destinations in a
microtubule- and ATP-dependent manner [1,2]. They play a signiﬁcant
role in neuronal development, synaptic functioning, intraﬂagellar
transport, and retinal outer segment renewal [2–5]. Kif17, a homo-
dimeric motor protein, binds speciﬁcally through its tail domain to the
postsynaptic density-95/disc large/zona occludens-1 (PDZ) domain of
Mint 1 (mLin10) within a large scaffolding protein complex that
transports vesicles containing the NR2B subunit of the NMDA receptors
(NMDARs) from the cell body exclusively to the dendrites [6]. Over-
expressing KIF17 enhances learning and memory [7], which is
dependent on NMDA receptors [8–10]. Likewise, up-regulating NR2B
increases the expression of KIF17, whereas down-regulating KIF17
reduces NR2B expression [11]. The positive relationship between KIF17and NR2B raises the possibility that the two may be co-regulated [11].
Our laboratory has recently found that neuronal NR2B and the
obligatory NR1 subunit of NMDA receptors are transcriptionally
regulated by nuclear respiratory factor 1 (NRF-1) [12], which also
regulates all subunits of cytochrome c oxidase (COX; [13]), a marker of
energy metabolism and neuronal activity [14]. The goal of the present
proposal was to test our hypothesis that NRF-1 also transcriptionally
regulates KIF17. By means of in silico analysis, electrophoretic mobility
shift and supershift assays, in vivo chromatin immunoprecipitation
assays, promoter mutations, and real-time quantitative PCR, we found
that NRF-1 indeed functionally regulates KIF17 in neurons.
2. Materials and methods
All experiments were carried out in accordance with the U.S.
National Institutes of Health Guide for the Care and Use of Laboratory
Animals and the Medical College of Wisconsin regulations. All efforts
were made to minimize the number of animals and their suffering.
2.1. Cell culture
Murine neuroblastoma N2a cells were obtained from the American
Type Culture Collection (ATCC, CCL-131). Cells were grown in
Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented with
Table 1
Aligned partial sequences of Kif17 promoter from rat (R), mouse (M), and human (H) genomes indicate conservation of atypical NRF-1 (A–B) binding sites. Conserved binding






Kif17 NRF-1A +3/+28 F 5′ TTTTGCGGCGGCGCCTGCAGCGCGGATCC 3′
R 3′ CGCCGCCGCGGACGTCGCGCCTAGGTTTT 5′
Kif17 NRF-1B −53/−25 F 5′ TTTTGCCGAGACGGCGTGCACGAGCGCGAGCG 3′
R 3′ CGGCTCTGCCGCACGTGCTCGCGCTCGCTTTT 5′
Kif17 NRF-2α −106/−81 F 5′ TTTTGCACTCGCCATTCCGTCCTGTGACG 3′
R 3′ CGTGAGCGGTAAGGCAGGACACTGCTTTT 5′
Kif17 NRF-1A
mutant
+3/+28 F 5′ TTTTGCGGCGGCGCCTTTTGCTTTGATCC 3′
R 3′ CGCCGCCGCGGAAAACGAAACTAGGTTTT 5′
Kif17 NRF-1B
mutant
−53/−25 F 5′ TTTTGCCGAGACGGCGTTTTCGAGTTTGAGCG 3′
R 3′ CGGCTCTGCCGCAAAAGCTCAAACTCGCTTTT 5′
Kif17 NRF-2α
mutant
−106/−81 F 5′ TTTTGCACTCGCCATAGAGTCCTGTGACG 3′
R 3′ CGTGAGCGGTATCTCAGGACACTGCTTTT 5′
Rat Cyt C −172/−147 F 5′ TTTTCTGCTAGCCCGCATGCGCGCGCACCTTA3′
R 3′ GACGATCGGGCGTACGCGCGCGTGGAATTTTT5′
COX4i1 +13/+36 F 5′ TTTTCGGGACCCGCTCTTCCGGTCGCGA 3′
R 3′ GCCCTGGGCGAGAAGGCCAGCGCTTTTT 5′
Positions of probes are given relative to TSP. Putative NRF-1 and NRF-2α binding sites
are in boldface. Mutated nucleotide sequences are underlined.
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mycin (Invitrogen, Carlsbad, CA) at 37 °C in a humidiﬁed atmosphere
with 5% CO2.
Rat primary cortical neurons were cultured as described previously
[15]. Brieﬂy, 1-day-old neonatal rat pups were anesthetized with CO2
and killed by decapitation. Brainswere removed from the skull, and the
meninges were removed. Visual cortical tissue was dissected, trypsi-
nized, and triturated to release individual neurons. These primary
cortical neuronswere then plated in 35 mmpoly-L-lysine-coated dishes
at a density of 50,000 cells/dish. Cells were maintained in Neurobasal-A
media supplemented with B27 (Invitrogen). Ara-C (Sigma, St. Louis,
MO) was added to the media to suppress the proliferation of glial cells.
2.2. In silico analysis of murine Kif17 promoter
DNA sequences surrounding the transcription start points (TSPs) of
Kif17 gene were derived from the mouse genome database in
GenBank™, as previously described [7]. These promoter sequences
encompassed 1 kb upstream and up to 200 bp downstream (excluding
protein-coding sequence) of the TSP of each gene analyzed. Computer-
assisted search for putative NRF-1 core binding sequences “GCGCAT/
CGC” or “GCGCAG/CGC” and for NRF-2α (GGAA or TTCC) were
conducted on Kif17 and Kif1a promoters. Kif1a was chosen because it
has a putative NRF-1 binding site, and NRF-2was chosen because it was
found previously to regulate all subunits of cytochrome c oxidase genes
[15,16], which NRF-1 also regulates [13]. Promoters of neuronal Kif3a
and Kif5b were also analyzed for putative NRF-1 binding sites.
Alignment of human, mouse, and rat promoter sequences was done as
previously described, using the Genome VISTA genome alignment tool
[15]. Murine Kif17 promoter sequence was compared with rat and
human genomic sequences using a 5-bp calculationwindow. Regions of
high homology and/or that contained known NRF-1 binding sites were
compared for the conservation of NRF-1 binding.
2.3. Electrophoretic mobility shift and supershift assays
In vitroNRF-1 andNRF-2α interactionswithKif17were assayedwith
EMSA using protocols as described previously [15]. Oligonucleotide
probes with putative NRF-1 (sites A and B) and NRF-2α binding sites on
the Kif17 promoter region were synthesized (Table 2A), annealed, and
labeled by a Klenow fragment ﬁll-in reaction with [α-32P]dATP (50 μCi/
200 ng). Each of the labeled probes was incubated with 2 μg of calf
thymus DNA and 5 μg of HeLa nuclear extract (Promega, Madison, WI)
and was processed for EMSA. For the supershift assays, 1–1.5 μg of
speciﬁc antibodies for the appropriate reactions were added to the
probe/nuclear extract mixture and the reaction was incubated for
20 min at room temperature. For the competition reactions, 100-fold
excess of unlabeled oligonucleotide was incubated with the nuclear
extract before adding the labeled oligonucleotide. All reactions were
loaded onto a 4% polyacrylamide gel and ran at 200 V for 2.5 h in 0.25×
TBE buffer. The results were visualized with autoradiography. Rat
cytochrome c with a NRF-1 binding site at position −172/−147 was
used as a positive control forNRF-1 andwas designed based on previous
report [17]. Similarly, COX4i1was used as a positive control for NRF-2α[15]. Mutants of NRF-1 and NRF-2α sequences as shown in Table 2A
were used as negative controls.
2.4. Chromatin immunoprecipitation assays
In vivo ChIP assays were performed using protocols as described
previously [12,18]. For each immunoprecipitation, ~750,000 primary
neurons were used and ﬁxed with 1% formaldehyde for 10 min at
room temperature. A ChIP assay kit (Upstate, Charlottesville, VA) was
used with minor modiﬁcations. The cells were resuspended in a
swelling buffer (5 mMPIPES, pH 8.0, 85 mMKCl, and 1% Nonidet P-40,
and protease inhibitors added right before use). The nuclei were
isolated by centrifugation and then sonicated. The sonicated lysate was
immunoprecipated with 0.2 μg of the appropriate (NRF-1, NRF-2α)
polyclonal rabbit antibodies or 2 μg of anti-nerve growth factor
receptor (NGFR) p75 polyclonal goat antibodies (C20 from Santa Cruz
Biotechnology, Santa Cruz, CA). NGFR was used as an antibody control,
as it should not immunoprecipitate any transcription factor.
Semi-quantitative PCR was performed with 1/20th of the precip-
itated chromatin, and primers targeting NRF-1 and NRF-2α sequences
were designed near the TSP of Kif17 and Kif1a genes (Table 2B) using
approaches as described previously [15]. Transcription factor B2 of
mitochondria (TFB2M) promoter, previously found to be activated by
NRF-1 in neurons [13], was used as a positive control, and exon 5 of
β-actin gene was used as a negative control (Table 2B). COX6a1
promoter, previously found to be activated by NRF-2α in neurons
[15], was used as a positive control. PCR reactions were carried out
with the EX Taq hot-start polymerase (TakaraMirus Bio, Madison,WI)
with the following cycling parameters: 30-s denaturation at 94 °C,
30-s annealing at 59.5 °C, and 20-s extension at 72 °C (32–36 cycles
per reaction). All reactions were hot-started by heating to 94 °C for
120 s. Use of hot-start polymerase and PCR additives (magnesium
and/or 0.5 M betaine (Sigma)) signiﬁcantly improved the quality and
Table 2B
ChIP assay primers.
Gene promoter Position Sequence Amplicon length
Kif17 NRF-1A&B −87 to +112 F 5′ TGACGTCACGGAGGTTGC 3′ 199 bp
R 5′ AAGTGTGCGGGCTGGAAC 3′
Kif17 NRF-2α −238 to −64 F 5′ CTTACCCTGCCTACCTCTGC 3′ 174 bp
R 5′ CTGGGCAACCTCCGTGAC 3′
Kif1a −154 to +43 F 5′ AACCTCGTCTCTTCTGTGCCGCTTT 3′ 197 bp
R 5′ GGAACTGATGCTTCTTACTGCCTG 3′
COX6a1 −163 to +96 F 5′ ATGGTACCTCACCCAGCAGCAGAGGAG 3′ 259 bp
R 5′ CCAGAGACTCGAGACGCACTC 3′
TFB2M promoter −64 to +115 F 5′ GAAGCGAGTGAGCAAAGGAC 3′ 179 bp
R 5′ GGTCCCCTCATCCTCCTCTA 3′
β-Actin exon5 −134 to +53 F 5′ GCTCTTTTCCAGCCTTCCTT 3′ 187 bp
R 5′ CGGATGTCAACGTCACACTT 3′
Positions of amplicons are given relative to TSP.
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gels stained with ethidium bromide.
2.5. Promoter mutagenesis study
A luciferase reporter construct of Kif17was created by PCR, and the
proximal promoter sequences were cloned using genomic DNA
prepared from mouse N2a cells as template, digested with KpnI and
HindIII, and the product was ligated directionally into pGL3 (Promega).
Site-directedmutagenesis of bothNRF-1 binding sites on each promoter
was produced using QuikChange site-directed mutagenesis kit (Strata-
gene, La Jolla, CA). Sequencing was used to verify all constructs.
The Kif17 promoter construct was transfected into N2a cells in a
24-well plate using Lipofectamine 2000 (Invitrogen). Each well
received 0.6 μg of reporter construct and 0.03 μg of pCMVβgal,
which constitutively expressed β-galactosidase. Transfected neurons
were stimulated with KCl at a ﬁnal concentration of 20 mM in the
culture media for 5 h as previously described [19]. After 5 h of
treatment, cell lysates were harvested and measured for luciferase
activity as described previously [13]. Data from six independent
transfections were averaged for each promoter construct.
2.6. Plasmid construction of NRF-1 shRNA
NRF-1 silencing was carried out using small hairpin RNAs
(shRNA) against murine NRF-1 (GenBankTM accession no. for NRF-1:
NM_010938) cloned into pLVTHM vector with H1 promoter and green
ﬂuorescent protein reporter (gift of Dr. P. Aebischer, Swiss Federal
Institute of Technology). Four shRNA sequences were selected: 5′-
GAAAGCTGCAAGCCTATCT-3′; 5′-GCCACAGGAGGTTAATTCA-3′; 5′-
GCATTACGGACCATAGTTA-3′; and 5′-AGAGCATGATCCTGGAAGA-3′,
with a linker sequence (5′-TTCAAGAGA-3′) and complementary
sequence for each to form the NRF-1-shRNA cassette. The pLL3.7/U6
promoter vector with puromycin resistance (Addgene, Cambridge,MA)
vectorwasused concurrently for puromycin selection. The emptyvectorTable 2C
PCR cloning primers.
Cloning primers Primer sequence
Grin1 F 5′AAGGTACCCGGCCGTCACACCTATTCT 3′
R 5′ AAAAGCTTGAAAAGGCGAAAAAGACAGC 3′
Kif17 F 5′ AAGGTACCGCGTGTGAACCTGCTTACAA 3′
R 5′ AAAAGCTTCCATCGAAGGTGAACTGCTT 3′
Mutagenesis primers
Grin1Mut F 5′ CAAGCATTTACGCCAACTTTGGCTTTTGTCAGGAGGCGCGCGCT 3′
R5′AGCGCGCGCCTCCTGACAAAAGCCAAAGTTGGCGTAAATGCTTG3′
Kif17 NRF-1Mut1 F 5′ GTCGTGCGGCGGCGCCTTTTGCTTTGATCCCCCGTT 3′
R 5′ AACGGGGGATCAAAGCAAAAGGCGCCGCCGCACGAC 3′
Kif17 NRF-1Mut2 F 5′ AACGGCGAACGCCGAGACGGCGTAAACGAAAACGAGCGTGA 3′
R ′'TCACGCTCGTTTTCGTTTACGCCGTCTCGGCGTTCGCCGTT 3′pLVTHM or scrambled shRNA in pLVTHM served as negative controls.
The basic gene cloning method was followed as described previously
[16]. Primary neurons were plated in 35-mm dishes at a density of 5 to
8×106 cells/dish. They were co-transfected 3 days post-plating with
NRF-1 shRNAexpression vectors (four sequences at equal amounts; 1 μg
total for primary neurons) and the pLL3.7/U6 vector for puromycin
resistance (1 μg for primary neurons) via NeuroFect™ (Genlantis, San
Diego, CA). Empty vectors or scrambled shRNA vectors alonewere used
at the same concentrations as vectors with shRNA against NRF-1.
Puromycin at aﬁnal concentration of 0.5 μg/mlwas added to the culture
medium on the second day after transfection to select for purely
transfected cells. Green ﬂuorescence was used to monitor transfection
efﬁciency. Transfection for primary cortical neurons was from 40% to
60%. However, puromycin selection effectively yielded 100% of
transfected cells. Cells were harvested after 48 h of silencing and lysed
for either protein or total RNA preparation.
To check for the effect of silencing NRF-2 on the expression of
Kif17, the same protocols as above were used with shRNA sequences
against NRF-2α as described previously [16].
To determine the effect of KCl stimulation, neurons transfected
with shRNA against NRF-1 were exposed to KCl at a ﬁnal concentra-
tion of 20 mM in the culture media for 5 h as described previously
[19]. Cells were then harvested for RNA isolation.
2.7. RNA isolation and cDNA synthesis
Total RNA was isolated by RNeasy kits (Qiagen, Valencia, CA)
according to the manufacturer's instructions. Three micrograms of total
RNAwas treatedwithDNase I and puriﬁedbyphenol-chloroform. cDNA
was synthesized using the iScript cDNA synthesis kit (Bio-Rad, Hercules,
CA) according to the manufacturer's instructions.
2.8. Real-time quantitative PCR
Real-time quantitative PCRs were carried out in a Cepheid Smart
Cycler Detection system (Cepheid, Sunnyvale, CA). SyBr Green
(BioWhittaker Molecular Application, Rockland, ME) and EX Taq
real-time quantitative PCR hotstart polymerase were used following
the manufacturer's protocols and as described previously [13]. Primer
sequences are shown in Table 3. PCR runs: hot start, 2 min at 95 °C;
denaturation, 10 s at 95 °C; annealing, 15 s according to the Tm of each
primer; and extension, 10 s at 72 °C for 15–30 cycles. Melt curve
analyses veriﬁed the formation of single desired PCR product. Rat 18S
was used as an internal control, and the 2−ΔΔCT method [20] was
carried out for the relative amount of transcripts.
2.9. Western blot assays
Control and NRF-1 shRNA samples were loaded onto 10% SDS-
PAGE gel and electrophoretically transferred onto polyvinylidene
Table 3
Primers for real-time PCR.
Gene Sequence Amplicon length Tm
Kif17 F 5′ AAGTGTGGGTGTAGAAGTGGCTGT 3′ 144 60°
R 5′ TGCTTCTCCCTCAGGTCCTTGTTT 3′
Kif1a F 5′ CATGAGCGCATCTTGTTTGCTCCA 3′ 196 60°
R 5′ ACACACCCAAGGTACCACCATCTT 3′
Grin2b F 5′ TCATGGTATCTCGCAGCAATGGGA 3′ 108 60°
R 5′ ACCGCAGAAACAATGAGCAGCATC 3′
Grin1 F 5′ TGGCTTCTGCATAGACCTGCTCAT 3′ 117 60°
R 5′ TTGTTGCTGTTGTTTACCCGCTCC 3′
NRF-1 F 5′ AAAAGGCCTCATGTGTTTGAGT 3′ 139 59.5°
R 5′ AGGGTGAGATGCAGAGAACAAT 3′
NRF-2α F 5′ CTCCCGCTACACCGACTAC 3′ 145 59.5°
R 5′ TCTGACCATTGTTTCCTGTTCTG 3′
18S F 5′ CGCGGTTCTATTTTGTTGGT 3′ 219 59.5°
R 5′ AGTCGGCATCGTTTATGGTC 3′
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incubated in primary antibodies (polyclonal antibodies against KIF17
(H-280, SC-50455, 1:200) and KIF1A (E-20, SC-19106, 1:100; Santa
Cruz Biotechnology). Monoclonal antibodies against β-actin (Sigma)
at 1:3000 dilution were used as loading controls. Blots were then
incubated in secondary antibodies (goat–anti-rabbit; Bio-Rad, rabbit–
anti-goat; Millipore), reacted with ECL, and exposed to autoradio-
graphic ﬁlm (Santa Cruz Biotechnology). Quantitative analyses of
relative changes were done with a Phospho Imager (Bio-Rad).2.10. NRF-1 over-expression and TTX treatment
pSG5NRF-1plasmid (gift ofDr. Richard Scarpulla)wasused forNRF-1
over-expression. Primary neurons were each plated in 35 mmdishes at
a density of 2 to 5×105 cells/dish. Neurons were co-transfected 3 days
post-plating with either 2 μg of the pSG5NRF-1 plasmid or an empty
vector plus 0.5 μg of pLL3.7 vector, using NeuroFect™ (Genlantis) at 1:3
ratio. Puromycin at a ﬁnal concentration of 0.5 μg/ml was added on the
second day after transfection to select for purely transfected cells. After
1 day of over-expression, TTX at a ﬁnal concentration of 0.4 μM was
added to the culture media for 4 days. Primary neurons were harvested
on the 5th day for RNA isolation.2.11. Statistical analysis
Signiﬁcance among group means was determined by analysis of
variance (ANOVA). Signiﬁcance between two groups was analyzed by
Student's t test. P-values of 0.05 or less were considered signiﬁcant.Fig. 1. NRF-1 and NRF-2α interactions in vitro with Kif17 gene promoter. (A–B) EMSAs
for NRF-1. 32P- labeled oligonucleotides, excess unlabeled oligos as competitors, excess
unlabeled mutant NRF-1 as competitors, HeLa extract, and NRF-1 antibodies are
indicated by a + or a − sign. Arrowheads indicate NRF-1 shift and supershift
complexes. The positive control, cytochrome c, shows a shift (A, lane 1) and a supershift
(A, lane 3) band. When excess unlabeled competitor was added, it did not yield any
band (A, lane 2). Kif17 promoter containing two putative NRF-1 binding sites (NRF-1A
and NRF-1B) showed speciﬁc shift and supershift bands that were eliminated by excess
unlabeled competitors (A, lanes 4, 7, and 6; B, lanes 1, 5, and 2, respectively). Labeled
mutated NRF-1 A and B sites on Kif17 were used as negative controls, and they did not
yield any band (A, lanes 9−11; B, lanes 6−8, respectively). Excess unlabeled but
mutated NRF-1 (containing both NRF-1A and B sites) could not compete (A, lane 5; B,
lane 3, respectively). Labeled oligos with NRF-1 antibodies alone with no HeLa extract
did not yield any band (A, lane 8; B, lane 4, respectively). (C) EMSA for NRF-2α. The
positive control, COX4i1, shows shift (C, lane 1) and supershift (C, lane 3) bands, while
excess unlabeled competitors did not yield any band (C, lane 2). Kif17 promoter had no
shift or supershift bands for NRF-2α (C, lanes 4 and 7). Labeledmutated NRF-2α site did
not yield any bands (C, lanes 9−11). Excess unlabeled and mutated NRF-2α sites did
not show any bands (C, lanes 5−6). Labeled oligos with NRF-2α antibodies alone did
not yield any band (C, lane 8).3. Results
3.1. In silico promoter analysis of Kif17 gene
Proximal promoters ofmurineKif17genewithDNAsequence 1 kb5′
upstream and 100 bp beyond 3′ of transcription start points (TSP) were
analyzed in silico for potential NRF-1 and NRF-2α binding sites
(Table 2A). Promoter showed two atypical sequence for NRF-1 binding
(A and B sites, Table 1) and both had the invariant GCA core described
previously for COX subunit genes [13]. There were two NRF-2α binding
sites but they were not tandem arrays. NRF-1 binding sites bore a high
(85–95%) homologywith both the rat and human Kif17 genes (Table 1).
Kif1a promoter also had atypical NRF-1 binding sites but without the
invariant GCA core. Itwas foundnot to functionally bind toNRF-1 and so
was used as a negative control in subsequent studies. Promoters of
neuronal Kif3a and Kif5b were also analyzed, and they did not contain
either typical or atypical NRF-1 binding sites.3.2. In vitro binding of Kif17 with NRF-1 and NRF-2α
In vitro electrophoretic mobility shift assays (EMSAs) were carried
out using 32P-labeled probes (Table 2A) to determine the speciﬁcity of
the two NRF-1 binding sites (A and B) in the promoters of murine
Kif17 (Fig. 1A–B). Rat cytochrome c promoter with a NRF-1 binding
site at positions −172/−147 served as a positive control [13], and it
formed speciﬁc DNA/NRF-1 shift and supershift complexes (Fig. 1A,
Fig. 2. (A−B) ChIP assays. Input lanes represent 0.5% and 0.1% of chromatin. TFB2M
promoter was the positive control for NRF-1, whereas COX6a1 promoter was the positive
control for NRF-2α. β-Actin was the negative control for both NRF-1 and NRF-2α. Kif17
promoter immunoprecipitated with NRF-1, whereas Kif1a did not. Anti-nerve growth
factor receptor p75 antibodies (NGFR) represent a negative control.Kif17promoter did not
immunoprecipitate with NRF-2α.
Fig. 3. Site-directed mutational analysis of both NRF-1 binding sites (A and B) on Kif17
and Grin1 promoters. Mutated NRF-1 binding sites (NRF-1A mut and NRF-1B mut) on
Kif17 and Grin1 subunit resulted in signiﬁcant reductions in luciferase activity as
compared to wild type (wt). (N=6 for each construct). *Pb0.05, **Pb0.01.
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added as a competitor, no shift band was formed (Fig. 1A, lane 2). To
rule out any non-speciﬁc antibody-oligonucleotide interactions,
labeled oligonucleotides were incubated with NRF-1 antibody
without HeLa nuclear extract, and no shift bands were observed
(Fig. 1A, lane 8; Fig. 1B, lane 4). As shown in Fig. 1A–B, Kif17 promoter
with both NRF-1A and B sites formed speciﬁc DNA–protein shift
complexes when incubated with puriﬁed HeLa nuclear extract
(Fig. 1A, lane 4; Fig. 1B, lane 1, respectively). Competition with excess
unlabeled probes eliminated these complexes (Fig. 1A, lane 6; Fig. 1B,
lane 2, respectively), whereas the addition of mutant NRF-1 probes
had no effect (Fig. 1A, lanes 5, and Fig. 1B, lane 3). A supershift band
was produced when anti-NRF-1 antibodies were added to shift assays
of Kif17 (Fig. 1A, lane 7 and Fig. 1B, lane 5, respectively). Kif17mutant
NRF-1 probes (A and B sites) yielded no band or complexes (Fig. 1A,
lanes 9–11 and Fig. 1B, lanes 6–8).
In vitro binding of Kif17 promoter to NRF-2αwas carried out using
32P-labeled probes (Table 1A). As shown in Fig. 1C, the rat COX4i1
promoter with NRF-2α site served as a positive control [15], and it
formed speciﬁc DNA/NRF-2α shift and supershift complexes (Fig. 1C,
lanes 1 and 3, respectively). Kif17 with putative NRF-2α sites yielded
no band or complexes (Fig. 1C, lanes 4–8). When an excess of
unlabeled probe was added as a competitor, no shift band was formed
(Fig. 1C, lane 2). Mutated NRF-2α sites did not show any bands
(Fig. 1C, lanes 9–11).
3.3. In vivo NRF-1 and NRF-2α interactions with Kif17 promoter
Chromatin immunoprecipitation assays (ChIP) were performed to
verify possible NRF-1 and NRF-2α interactions with Kif17 promoter in
vivo.β-actin exon 5 served as a negative control,whereas transcription
factor B2 of mitochondria (TFB2M) with a known NRF-1 binding site
[13] and COX6a1 with known NRF-2α sites [15] served as positive
controls. Parallel immunoprecipitation assays were carried out with
the sameneuronal cell lysates andNRF-1 andNRF-2α antibodies. Anti-
nerve growth factor receptor p75 antibodies (NGFR) served as a
negative immunoprecipitation control. Polymerase chain reactions
(PCRs) using primers shown in Table 2B were done to determine
which promoters interactedwithNRF-1 andNRF-2α in vivo. Individual
0.5% and 0.1% dilutions of input chromatin were used as standards to
indicate the efﬁciency of the PCRs (Fig. 2A–B). Kif17 and TFB2M each
produced a band from DNA co-immunoprecipitated with anti-NRF-1
antibodies at a position identical to that from the genomic DNA control
(input) (Fig. 2A). On theother hand,Kif1a andβ-actin yieldednobands
(Fig. 2A). COX6a1 produced a band from DNA co-immunoprecipitated
with anti-NRF-2α antibodies at a position identical to that from the
genomic DNA control (input) (Fig. 2B), whereas Kif17 and β-actin
yielded no band (Fig. 2B). In all cases, co-immunoprecipitation with
NGFR antibodies did not yield any PCR product.
3.4. Mutational analysis of NRF-1 binding
Based on EMSA probes (Table 2A) that formed NRF-1 speciﬁc
complexes (Fig. 1A, B), site-directed mutations of these same putative
NRF-1 binding sites on Kif17 and previously studied Grin1 promoters
[12] were constructed (Table 2C), generated in luciferase reporter
plasmids, and analyzed by gene transfection. As shown in Fig. 3,
mutation of either NRF-1 A or B binding site on Kif17 as well as on
Grin1 led to ~35–60% reduction in promoter activity of these genes
(Pb0.05–0.01). Grin1 subunit promoter served as a positive control
and conﬁrmed our previous report [12].
3.5. NRF-1 silencing by RNA interference
To determine the effect of silencing NRF-1 transcript on the
expression of NMDA receptors and Kif17, plasmid vectors expressingsmall hairpin RNA (shRNA) against four target sequences of NRF-1
mRNA were used. These vectors were previously found to silence
NRF-1 expression in neurons [12]. Transfection of neurons with
shRNA vectors resulted in~70–78% decrease in levels of KIF17 and
NRF-1 protein as measured by western blots (Pb0.05) (Fig. 4A).
However, KIF1A showed no appreciable alterations in protein levels
(Fig. 4A). To determine that this effect was not limited to N2a cells,
cDNAs from primary cortical neurons (Fig. 4B) transfectedwith NRF-1
shRNA vectors, scrambled shRNA vectors, or empty vectors were
analyzed with quantitative real-time PCRs. As shown in Fig. 4B, mRNA
levels of NRF-1, Kif17, Grin1, and Grin2b were signiﬁcantly reduced in
primary neurons transfected with shRNA as compared to those
transfected with empty vectors. The extent of reduction ranged
between 62% and 78% (Pb0.05). On the other hand, the expressions of
Kif1a and nuclear respiratory factor 2α (NRF-2α, a negative control)
remained unchanged. The scrambled shRNA also did not have any
effect on any mRNA level tested (Fig. 4B).
Fig. 4. RNA interference-mediated silencing of NRF-1 suppresses mRNAs of Kif17 and
NMDAR subunit genes. (A) Western blot reveals a down-regulation of KIF17 and NRF-1
protein levels in shRNA-transfected neurons, whereas KIF1A protein levels were not
affected. β-Actin served as a loading control. (B) Primary neurons were transfected with
shRNA against NRF-1 (dotted bars) or with empty vectors (black bars) or with
scrambled shRNA (hatched bars). NRF-2α served as a negative control. NRF-1, Kif17,
Grin1, and Grin2b subunit mRNAs were signiﬁcantly reduced in shRNA-treated samples
as compared to those with empty vectors, whereas Kif1a and NRF-2αmRNAs remained
unchanged. N=6 for each data point. *Pb0.05.
Fig. 5. Depolarization-induced up-regulation of promoter gene expressions and mRNA
levels of Kif17 and NMDAR subunit genes in neurons and the effects of NRF-1 binding
site mutation and NRF-1 silencing. (A) Site-directed mutations of NRF-1 binding sites
on Kif17 promoter resulted in a signiﬁcant reduction in luciferase activity as compared
to the wild type (wt). KCl depolarization increased promoter activity in the wild type
but not in the mutated Kif17 (NRF-1A mut and NRF-1B mut sites). (Group means were
analyzed for overall statistical signiﬁcance using the Student's t-test and ANOVA, N=6
for each construct). *Pb0.05, as compared to Kif17 wild type. #Pb0.05 as compared to
Kif17wt with KCl depolarization. (B) Data from real-time quantitative PCR indicate that
NRF-1, Kif17, Kif1a, Grin1, and Grin2b gene expression in neurons were increased by KCl
depolarization as compared to controls. NRF-1 silencing with shRNA prevented the
up-regulation of NRF-1, Kif17, Grin1, and Grin2b mRNAs by KCl, whereas Kif1a was not
affected. Values represent mean±SEM of combined data from 3 independent
experiments. *Pb0.05, **Pb0.01 versus controls. All #P values were compared to
20 mM KCl-treated samples (#Pb0.05). (C) Western blot reveals increased protein
levels for both KIF17 and KIF1A following KCl depolarization as compared to controls.
NRF-1 silencing with shRNA prevented the KCl-induced up-regulation of KIF17 protein
levels, whereas those of KIF1A were not affected. *Pb0.01 versus controls. β-Actin
served as a loading control.
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[16] did not yield any statistically signiﬁcant difference in the
expression of Kif17 (data not shown), consistent with the negative
EMSA and ChIP data.
3.6. Response of Kif17 promoter to KCl depolarizing stimulation
To determine if depolarizing stimulation altered the expression of
Kif17 gene in N2a cells, 20 mM of potassium chloride was added to
the culture media for 5 h, a mild regimen previously found to
activate NRF-1 and COX gene expression in primary neurons
[19,21,22]. As shown in Fig. 5A for N2a cells, depolarizing
stimulation resulted in a signiﬁcant increase (~109%) in the activity
of Kif17 promoter as monitored by luciferase assays (Pb0.05). This
increase was abolished by mutating either the NRF-1 A or B site,
conﬁrming a link between KCl-induced depolarization and the
activation of Kif17 via NRF-1 binding.
3.7. Effect of NRF-1 silencing on Kif17, Grin1, and Grin2b mRNAs and
protein in the presence of KCl stimulation
To ensure that NRF-1 has a functional effect on primary neurons,
these neurons were transfected with shRNA against NRF-1 and were
then subjected to 20 mM KCl for 5 h. As shown in Fig. 5B,
depolarizing stimulation without gene silencing resulted in a
signiﬁcant increase in the expressions of NRF-1, Kif17, Kif1a, Grin1,
and Grin2b genes, as monitored by real-time quantitative PCR
(Pb0.05, Pb0.01). The increase ranged from 180% to 470%, indicating
that KCl has a general stimulatory effect on transcription (at least of
the genes tested). However, in the presence of NRF-1 silencing, KCl
was no longer able to up-regulate mRNA levels of NRF-1, Kif17,Grin1, and Grin2b. On the other hand, NRF-1 silencing did not
prevent Kif1a from being up-regulated by KCl, and the levels
remained higher than those of controls but not different statistically
from those with KCl alone (Fig. 5B).
As shown in Fig. 5C, depolarizing stimulation without gene
silencing resulted in a signiﬁcant increase in the protein level of
KIF17 (132%, Pb0.01), whereas that of KIF1A was increased but not
signiﬁcantly different from controls. Transfection of neurons with
NRF-1 shRNA vectors in the presence of KCl stimulation resulted
in~80% decrease in the level of KIF17 protein as measured by
western blots (Pb0.01) (Fig. 5C). However, KIF1A showed no
statistically signiﬁcant alterations in protein levels under the same
treatment (Fig. 5C). These results conﬁrmed the speciﬁcity of NRF-1
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increased neuronal activity.
3.8. NRF-1 over-expression increased Grin1 and Kif17 mRNA levels and
rescued neurons from tetrodotoxin-induced transcript reduction
A low concentration of TTX (0.4 μM) has been shown to decrease
the level of COX subunit mRNAs as well as COX enzyme activity in vivo
and in primary neurons [21,23]. To determine if over-expression of
NRF-1 could rescue not only COX but also Kif17 transcript, a
pSG5NRF-1 construct (gift of Dr. Richard Scarpulla) for NRF-1
over-expression was transfected into primary neurons that were
then exposed to TTX (0.4 μM) for 4 days. When neurons were
transfected with empty vectors, exposure to TTX led to a 66%
reduction in Grin1 and a 73–75% reduction in Kif17 and Kif1a mRNA
levels (Fig. 6A–C), indicating an overall suppressive effect of TTX on
gene expression in neurons. Neurons transfected with the pSG5NRF-
1 construct had a 338% increase in mRNA levels of Grin1 (Pb0.05)
(Fig. 6A) and a 219% increase in Kif17 mRNA levels (Pb0.05)
(Fig. 6B) as compared to empty vector controls, but no statistically
signiﬁcant change in Kif1a level was evident (Fig. 6C). When
exposed to TTX, neurons transfected with pSG5NRF-1 expressed
145–157% more Grin1 and Kif17 transcripts as compared to those
with empty vectors (Pb0.05) (Fig. 6A–B). No statistically signiﬁcant
increase was found for Kif1a (Fig. 6C). These results conﬁrmed that
NRF-1 could rescue Grin1 and Kif17 mRNAs but not that of Kif1a in
the presence of TTX.
Neurons exposed to TTX had ~40–70% decrease in levels of KIF17
and KIF1A proteins as compared to controls in western blots (Pb0.01)
(Fig. 6D). Neurons transfected with NRF-1 and exposed to TTX
expressed 50% more KIF17 protein as compared to TTX aloneFig. 6. NRF-1 over-expression in primary neurons signiﬁcantly increased mRNA levels for Ki
Kif1amRNA levels (A–C) were all reduced by TTX as compared to controls. Over-expression o
expression of NRF-1 was able to rescue Grin1 and Kif17, but not Kif1a from TTX-induced dow
Student's t-test (N=6 for each group). All *P values were compared to empty vectors (*Pb0
were compared to NRF-1 over-expression (XPb0.05). (D) Protein levels for KIF17 and KIF
However, NRF-1 over-expression rescued protein levels of KIF17, but not of KIF1A, from be
values were compared to TTX (#Pb0.01).(Pb0.01). However, NRF-1 over-expression could not rescue KIF1A
protein levels after TTX exposure, conﬁrming the speciﬁcity of NRF-1
on KIF17 (Fig. 6D).
4. Discussion
The present study documents for the ﬁrst time that KIF17 is
regulated by the same transcription factor, NRF-1, as its cargo NR2B
of NMDA receptors, thereby linking transport motor and synaptic
cargo associated with glutamatergic neurotransmission at the
transcriptional level of regulation in neurons. The high homology
of NRF-1 binding sites among mice, rats, and humans for Kif17
(Table 1), Grin2b, and Grin1 [12] genes underscores the conservation
of such co-regulation throughevolution. Theﬁndings are speciﬁc in that
NRF-1 (but not NRF-2) regulates Kif17 (but not Kif1a) (the present
study) and Grin2b (but not Grin2a) [12].
The kinesin superfamily of motor proteins is encoded by 45
genes, classiﬁed into 15 families (numbered kinesin 1 to 14B), and
grouped into 3 types (N-, M-, and C-) depending on the location of
the motor domain in the protein [2]. KIF17 (also known as OSM3) is
a member of the N4 kinesin-2 family, with its motor domain in its
N-terminus, and it is neuron-speciﬁc [6,24]. Unlike its family
member KIF3, which transports synaptic vesicles down the axons,
KIF17 moves vesicles containing the NR2B and NR1 subunits of the
NMDA receptors along microtubules from the cell body strictly to
dendrites in a plus-end-directed, ATP-dependent manner. The head
domain of KIF17 interacts with microtubules, while its tail domain
interacts with the PDZ domain of the scaffolding protein MINT1
(LIN10), which forms a complex with LIN2 and LIN7 to support the
NR2B-containing cargo vesicles [2,6]. Over-expression of KIF17 in
transgenic mice increased both the mRNA and protein levels off17 and Grin1 genes and rescued them from TTX-induced suppression. Grin1, Kif17, and
f NRF-1 signiﬁcantly increased transcript levels of Grin1 and Kif17, but not of Kif1a. Over-
n-regulation. Group means were analyzed for overall statistical signiﬁcance using the
.05). All #P values were compared to empty vector plus TTX (#Pb0.05), and all XP values
1A were all reduced with TTX impulse blockade as compared to controls in neurons.
ing down-regulated by TTX. All *P values were compared to controls (*Pb0.01). All #P
Fig. 7. Schematic representation of transcriptional co-regulation by a common
transcription factor, NRF-1. Genes for KIF17, NMDA receptor subunits NR1 and NR2B,
as well as COX subunits are all regulated by NRF-1. Thus, NRF-1 coordinates the tight
coupling between glutamatergic synaptic transmission and energy metabolism at the
molecular level in neurons.
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Likewise, an up-regulation of NR2B in hippocampal neurons with
the NMDA receptor antagonist APV led to an increased level of
KIF17 [11]. On the other hand, a knockdown of KIF17 expression
with antisense oligonucleotides reduced NR2B expression and its
synaptic localization [11]. These parallel changes strongly suggest
co-regulation of KIF17 and NR2B [11], and the present study
provides solid evidence for such a co-regulation at the transcrip-
tional level. NRF-1 regulates the expression of not only Grin2b
(NR2B) and the obligatory Grin1 (NR1) subunits of the NMDA
receptors [12], but also their transporter motor Kif17 in neurons
(the present study). Signiﬁcantly, the NR2A subunit of the NMDA
receptors responds to perturbations of KIF17 in a direction opposite
to that of NR2B [11], and it is neither transported by KIF17 [11] nor
regulated by NRF-1 [12].
The NMDA receptors are important for glutamatergic synaptic
transmission, synaptic plasticity, circuit development, learning, and
memory [8–10]. Functional NMDA receptors contain heteromeric
combinations of NR1 subunit and one or more of NR2A-D subunits
[25]. In isolation, NR1 (Grin1) gene expresses a functional receptor
with a weak response activated by glutamate and glycine, whereas
none of the NR2 (Grin2) subunits is functional when expressed
alone [26]. In the adult cortex, 40% of NMDA receptors are
composed of NR1/NR2B subunits, 37% are made of NR1/NR2A, and
only 6% are a combination of all threes subunits [27,28]. However,
the NR2B subunit appears to be critical for a number of basic
structural and functional attributes associated with the NMDA
receptor. This subunit predominates in the forebrain and hippo-
campus and is essential for the synaptic localization of the NMDAR
channel [29,30]. Moreover, the cytoplasmic tail of NR2B mediates
protein interaction independent of its channel participation, and it
is necessary for long-term potentiation even when its role in
channel formation is decreasing with development, whereas NR2A
is not necessary for LTP [31]. The importance of NR2B in learning
and memory is likely to be the basis for its continual transpor-
tation into the dendrites via KIF17 motor through postnatal
development and into adulthood [6], as well as for their co-
regulation by the same transcription factor NRF-1 (the present
study).
NRF-1 is known to be a key transcriptional activator of nuclear
genes encoding a number of mitochondrial respiratory enzymes,
including subunits of the ﬁve respiratory chain complexes [32–34].
Recently, we found that NRF-1 regulates all 13 subunits of
cytochrome c oxidase derived from the nuclear and mitochondrial
genomes [13]. Thus, NRF-1 plays a signiﬁcant role in coordinating
the two genomes in critically regulating the expression of an
enzyme vital for energy generation. Energy in neurons is used
primarily to repolarize membrane potentials subsequent to
glutamate-induced depolarization, and neuronal activity and
energy metabolism are tightly coupled processes [14]. Under
conditions of altered neuronal activity, such as afferent impulse
blockade by TTX or depolarizing treatment with KCl, neuronal COX
activity is adjusted to match the new energy demand [14,23], and
the expressions of glutamate and NMDA receptors are adjusted in
parallel [12,23,35]. Likewise, NRF-1 protein and mRNA levels are
up-regulated by depolarizing neuronal activity [19] and down-
regulated by TTX-induced impulse blockade in vitro or afferent
removal in vivo [22]. These changes preceded those of NRF-1's
target genes, such as cytochrome c oxidase [19,22]. Thus, NRF-1
itself is directly regulated by neuronal activity. Remarkably, NRF-1
also directly regulates the expression of critical components of
glutamatergic synapses, including NR1 and NR2B of the NMDA
receptors, subunit GluR2 of the AMPA receptors, and neuronal
nitric oxide synthase [12,36,37]. Thus, the tight coupling of
neuronal activity and energy metabolism is extended to the
molecular level of regulation. The present study adds a thirddimension to the coupling by documenting that NRF-1 also
regulates the expression of the NR2B transporter protein KIF17
that is highly ATP-dependent. A knockdown of NRF-1 expression
with shRNA reduced both message and protein levels of Kif17
(KIF17), Grin1 (NR1), and Grin2b (NR2B) and prevented them
from being up-regulated by KCl depolarization, whereas an over-
expression of NRF-1 up-regulates the transcripts of all three genes
and rescued them from being suppressed by TTX [12,36,37; the
present study]. On the other hand, perturbations of NRF-1 do not
affect the expression of Kif1a, whose protein is not known to be
involved in NMDA receptor transportation. Of signiﬁcance is the
fact that dendrites, to which KIF17 exclusively targets and where
NR1 and NR2B subunits of NMDA receptors are enriched, are also
the major energy consumers of the brain [14]. Dendrites represent
the major receptive sites for excitatory synapses, and their
membranes have to be constantly repolarized after depolarization,
a highly energy-demanding process fueled by ATP generated from
oxidative metabolism. For this reason, the level of COX is also the
highest in dendrites [14]. Thus, the tightly coupled regulatory
mechanism via NRF-1 is exquisitely coordinated, efﬁcient, and
precise.
5. Conclusions
In conclusion, the present study documents that the same
transcriptional regulator NRF-1 coordinately regulates the expres-
sions of Kif17, Grin1, and Grin2b subunit genes of NMDA receptors, as
well as previously reported COX subunit genes in neurons. This
ensures that the production and transportation of critical receptors
of glutamatergic neurotransmission is tightly coupled to energy
generation via the oxidative pathway (Fig. 7). No doubt, NRF-1 may
not act alone. CREB, Sp1, and AP1 binding sites have been reported
on the Kif17 promoter that may play additional regulatory roles in
the transcription of the Kif17 gene, but they have not been
functionally characterized in neurons [7]. Future studies can be
directed at elucidating these issues.
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